PATH
banner
path.org
PATH
@path.org
PATH is a global team of innovators working to increase health equity so people, communities, and economies can thrive.

Learn more: https://www.path.org
Join us on Dec 3 for the last #PATHLiveForum of 2025! 🦟

Interventions that reduce mosquito populations & prevent bites are essential to the effort to #EndMalaria. This session will spotlight lessons learned from rolling out new #VectorControl innovations.

Register: https://bit.ly/3XeV1ic
November 25, 2025 at 2:31 PM
Polio could become just the 2nd disease in history to be wiped out.

PATH helped lead the creation of a next-gen oral polio vaccine—already used in 2 billion doses.

Together, we can finish the job. Be the way to better health for millions. https://bit.ly/3X5C8y0

#EndPolio #VaccinesWork
November 21, 2025 at 6:56 PM
Reposted by PATH
If malaria prevention collapses, Africa could lose $83B in GDP by 2030.

Investing in @globalfund.bsky.social protects children, strengthens health systems & fuels economic growth.

🤝Solidarity matters.

INSIDE VIEW: Duma Boko, President of Botswana

📖⬇️ & 🙏🔁
healthpolicy-watch.news/investing-in...
Investing In The Global Fund Is Smart Economics, Not Charity - Health Policy Watch
The Global Fund to Fight AIDS, Tuberculosis and Malaria provides nearly 60% of international financing for malaria. Ahead of its Replenishment campaign on
healthpolicy-watch.news
November 21, 2025 at 12:04 PM
🎬 Watch: Can AI safely support #MentalHealth? On the @devex.com podcast, PATH's Bilal Mateen joins colleagues from SAHPRA & @wellcometrust.bsky.social to discuss how #AIForHealth can help expand access to care and what regulations are needed to keep patients safe.
Bilal Mateen, Miranda Wolpert, and Christelna Reynecke join Devex’s Catherine Cheney for a special edition podcast on artificial intelligence’s role in supporting mental health.
Can AI safely support mental health?
Can AI safely support mental health?
www.devex.com
November 20, 2025 at 7:29 PM
While current malaria vaccines are already saving lives, new vaccines & #mAbs are being developed to accelerate malaria elimination.

A new @who.int-commissioned, PATH-led article in @elsevierlsj.bsky.social assesses the potential value of next-gen vaccines & mAbs: https://bit.ly/3X5qtiO

#MedSky
Value profile for Malaria vaccines and monoclonal antibodies
Malaria remains a leading cause of morbidity and mortality and is responsible for over 0.5 million annual deaths globally. During the first two decade…
www.sciencedirect.com
November 20, 2025 at 2:25 PM
If we can’t talk about diarrhea, we can’t defeat it. That's why we launched DefeatDD in 2010: to break the poo taboo 💩❤️ and increase investment in vaccines & other prevention tools.

Since then, 120+ countries have introduced the #rotavirus vaccine!

#WorldToiletDay
November 19, 2025 at 4:05 PM
Civil society is leading the way on #OxygenAccess. We applaud CSO coalitions for medical oxygen access in Kenya, Malawi, Tanzania & Zambia for turning evidence into advocacy so everyone can breathe easier.

Learn more and join the movement: https://bit.ly/3Lw2A1l

#EveryBreathCounts #InvestInOxygen
CSO Coalitions for Medical Oxygen Access
Stronger country voices toward healthier oxygen ecosystems.
www.path.org
November 19, 2025 at 1:22 PM
💉 The November edition of PATH Insights is out now. Read about PATH's role in the big push to #EndPolio, plus #OneHealth projects in Southeast Asia and #HepC prevention amid the war in Ukraine: https://bit.ly/43WBrtU
November 18, 2025 at 3:19 PM
What will it take to end the tuberculosis epidemic by 2030? At #WCLH2025 this week, we're sharing lessons learned from TB projects in Myanmar, Ukraine, India, and more.

See our full schedule: bit.ly/43YHQ8E

#UnionConf #EndTB @theunion.org
November 18, 2025 at 2:00 PM
Reposted by PATH
We know that school-based #HPV vaccination programs are a great way to expand access, but what about girls who aren't in school?

Great blog for World #CervicalCancer Elimination Day from our partners at @path.org with insights into reaching out-of-school girls with #HPVvaccines.
For World #CervicalCancerElimination Day, we’re sharing new results from a 7-country study on strategies for reaching out-of-school girls with HPV vaccination: https://bit.ly/49tTXyh

#VaccinesWork #EndCervicalCancer
November 17, 2025 at 9:40 PM
For World #CervicalCancerElimination Day, we’re sharing new results from a 7-country study on strategies for reaching out-of-school girls with HPV vaccination: https://bit.ly/49tTXyh

#VaccinesWork #EndCervicalCancer
November 17, 2025 at 6:05 PM
#Typhoid is a serious public health threat in many parts of the world. We can prevent it with vaccines—but to ensure access, we need more of them.

That's why PATH supported a study of #EuBiologics’ new typhoid vaccine. Results are promising: https://bit.ly/4r8aBKb

#VaccinesWork #TakeOnTyphoid
More vaccines, more protection: Promising results for new typhoid conjugate vaccine
Phase 3 results from a trial of a new typhoid conjugate vaccine show positive results, offering the potential for an additional product to increase access.
www.path.org
November 17, 2025 at 2:27 PM
PATH's Bilal Mateen appeared on the @bmj.com Future Health Podcast this week! Tune in to the full episode to hear Bilal's take on ambient voice technology, data colonialism, anglocentric LLMs, & much more:

🎬 https://bit.ly/47Ub1uK
🎧 https://bit.ly/4nTMYSE

#GenAI #AIForHealth #GlobalHealth
Slang, Accents, and Algorithms: Teaching AI to Understand Real Patients - Dr. Bilal Mateen
YouTube video by BMJ Future Health
youtu.be
November 14, 2025 at 2:51 PM
Today marks the halfway point in @who.int’s roadmap to #DefeatMeningitis by 2030.

We’ve seen incredible progress, but there's more to be done. We're proud to stand with Meningitis Research Foundation & many others in this effort to save lives & create a future without #meningitis.

bit.ly/4nVMX0q
Halfway to 2030
Now is the time for government action to defeat meningitis.
www.meningitis.org
November 13, 2025 at 7:37 PM
#JustPublished in @lancetgh.bsky.social: results from a Phase 3 clinical trial of #EuBiologics’ typhoid conjugate vaccine. The vaccine demonstrates strong safety & immunogenicity—a crucial step toward a sustainable supply of lifesaving typhoid vaccine. https://bit.ly/47HyvVe

#TakeOnTyphoid
EuTYPH-C Inj.® Multi-dose demonstrates strong safety and immunogenicity: Results now available from a Phase 3 study
bit.ly
November 13, 2025 at 2:35 PM
Safe, affordable medical oxygen is essential to ending deaths from pneumonia and beyond.

By procuring key supplies to keep equipment running, we turned oxygen availability into #OxygenAccess across 6 African countries: https://bit.ly/4p9VOwB

#WorldPneumoniaDay #GO2AL
Turning oxygen availability into oxygen access: An initiative to keep essential equipment running
Health systems require the right supplies and equipment to keep oxygen flowing. Supported by the Oxygen Delivery Gap Fund, PATH helped turn oxygen availability into respiratory care access across six ...
bit.ly
November 12, 2025 at 3:57 PM
Maternal #RSV vaccines have exciting potential to protect infants from #pneumonia and severe respiratory illness.

📣 Use our RSV communications toolkit to spread the word about new immunization products for protecting infants: https://bit.ly/4ok3We0

#WorldPneumoniaDay
November 12, 2025 at 1:59 PM
This week, PATH is excited to participate in the @astmh.bsky.social Annual Meeting in Toronto. We'll present new insights into #malaria & other tropical diseases and share innovative, data-driven strategies addressing #GlobalHealth challenges.

See our full schedule: bit.ly/4our9tT

#TropMed25
November 11, 2025 at 2:57 PM
#RSV is a major cause of pneumonia in infants. But maternal RSV vaccines, now prequalified by @who.int, can offer a path forward to protect the most at-risk children.

More here: https://bit.ly/3LjFEC5

#WorldPneumoniaDay
One step closer to protection: Setting the stage for maternal RSV vaccine introduction
With new global recommendations in place, countries are poised to take next steps toward introducing maternal RSV vaccines and safeguarding infants from a major health threat.
bit.ly
November 11, 2025 at 12:47 PM
Reposted by PATH
For many babies, RSV is more than a seasonal illness, it’s a deadly threat, especially for children in lower-income countries. A new maternal vaccine could change that, shielding infants from the moment they’re born. Read more about this live-saving development: bit.ly/4oUF4JM via @path.org
November 5, 2025 at 2:38 PM
#RSV is the top cause of severe respiratory infections and hospitalization in infants and young children.

During #RSVAwareness Week, we outline this year's exciting progress toward introducing RSV vaccines in countries with the greatest burden: https://bit.ly/43LEHcb
November 4, 2025 at 7:25 PM
Reposted by PATH
On #OneHealthDay, we’re spotlighting smarter ways to fund health sustainably.

In our latest guest piece, Dr Gabby Laing of @unlimithealth.bsky.social argues that #OneHealth isn’t just a buzzword—it’s a smarter investment strategy.

Read here 👉 actionforglobalhealth.org.uk/one-health-f...
Beyond Aid: Why One Health Is the Future of Global Health Financing | Action for Global Health
Discover how the One Health approach transforms global health financing by uniting human, animal, and environmental health for lasting impact.
actionforglobalhealth.org.uk
November 3, 2025 at 9:11 PM
Reposted by PATH
One Health is the idea that human, animal, and environmental health are closely connected.

#OneHealth is a team sport, and a successful approach involves agencies working together to improve the health of people, animals – including pets, wildlife, and livestock - and our shared environment.
November 3, 2025 at 9:25 PM
To achieve #HealthForAll, we need climate-resilient health systems. 🌾🗺️

At PATH, we take a #OneHealth approach: uniting experts in human, animal, & environmental health so countries can detect health threats early, prevent outbreaks, and respond more effectively when crises arise.

#OneHealthDay
November 3, 2025 at 4:35 PM